In a picture: Hunting down guerrilla tumour cells – Prof. Rolf Bjerkvig

Brain tumours contain many different types of cells, here stained different colours, which makes them complex to treat.

Professor Rolf Bjerkvig, a specialist in brain cancer research, tells us why guerrilla cells make the disease so hard to treat. Brain tumours are hard to treat completely with surgery because they leave behind cells that invade the brain. In this video, which covers 72 hours, you can see cells breaking off from a tumour to invade other … Read more

Scientists can predict rare leukaemia 8 years before symptoms begin

Image Credit: National Cancer Institute

A study of more than half a million blood samples has allowed scientists to pinpoint the risk factors for a rare type of leukaemia, enabling them to predict if someone will develop the disease eight years before symptoms appear and opening the door to preventative treatments. Acute myeloid leukaemia (AML) is a rare cancer usually … Read more

Family’s grief sparks a quest for better bladder cancer cures

Millions of lives are lost to cancer due to late detection so scientists are working on better ways of diagnosing the disease.

‘Invasive and uncomfortable’ prodedures for detecting if someone has bladder cancer could be replaced by urine tests that not only screen for the presence of the disease but also help doctors choose the right course of treatment for a particular patient. ‘Our lives literally came to a stop when my mother was diagnosed with cancer,’ said … Read more

Europe is in danger of being out-innovated in regenerative medicine – Prof. Ton Rabelink

With the right environments, stem cells can potentially be reprogrammed to grow kidney tissue.

by Frieda Klotz Regenerative medicine should be governed, firstly, by the principle of do no harm, but a better balance between risk and regulation is required to bring innovations to market more quickly, according to Ton Rabelink, professor of internal medicine and head of nephrology at Leiden University in the Netherlands. He says that Europe is in … Read more

Cell factories mass-produce living drugs

The CliniMACS Cell Factory at Miltenyi Biotec's facilities in Germany automates the production of cell therapy for patients with blood cancer.

Table-top cell production factories and placentas harvested after birth are promising to bring life-saving cell therapies to unprecedented numbers of patients. The techniques could potentially help to turn the tide on chronic diseases and certain forms of cancer by providing much-needed upscaling for regenerative medicine. ‘You insert the blood here, press the button, follow the steps and … Read more